FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 66 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $955,000 | -61.6% | 205,870 | -59.0% | 0.01% | -60.0% |
| Q1 2017 | $2,488,000 | -65.7% | 502,579 | -23.1% | 0.02% | -66.7% |
| Q4 2016 | $7,258,000 | +20.6% | 653,841 | +0.6% | 0.06% | +7.1% |
| Q3 2016 | $6,020,000 | +66.5% | 650,125 | +14.2% | 0.06% | +64.7% |
| Q2 2016 | $3,616,000 | -0.6% | 569,403 | +2.1% | 0.03% | +3.0% |
| Q1 2016 | $3,637,000 | -17.0% | 557,849 | +3.2% | 0.03% | -29.8% |
| Q4 2015 | $4,384,000 | +17.2% | 540,602 | +6.0% | 0.05% | +6.8% |
| Q3 2015 | $3,740,000 | -61.3% | 510,191 | -45.9% | 0.04% | -21.4% |
| Q2 2015 | $9,658,000 | +419.2% | 942,196 | +368.6% | 0.06% | +115.4% |
| Q1 2015 | $1,860,000 | +42.4% | 201,070 | +7.9% | 0.03% | +18.2% |
| Q4 2014 | $1,306,000 | +31.3% | 186,289 | +2.0% | 0.02% | +10.0% |
| Q3 2014 | $995,000 | – | 182,609 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|